Canlyniadau Chwilio am Awdur

1

Tumours outside the mutation box gan Rogier Versteeg

Cyhoeddwyd 2014

Cael y testun llawn Cael y testun llawn
Carta

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

c-myc down-regulates class I HLA expression in human melanomas. gan Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters, D. J. Ruiter, Peter I. Schrier

Cyhoeddwyd 1988

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression gan Fieke Lamers, Linda Schild, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar

Cyhoeddwyd 2011

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines gan Monique H. A. Kester, George G. J. M. Kuiper, Rogier Versteeg, Theo J. Visser

Cyhoeddwyd 2006

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene gan Gerben Schaaf, Mohamed Hamdi, Danny A. Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool

Cyhoeddwyd 2010

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma gan Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma gan Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg

Cyhoeddwyd 2013

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells gan Jens Bunt, Nancy E. Hasselt, Danny A. Zwijnenburg, Mohamed Hamdi, Jan Köster, Rogier Versteeg, Marcel Kool

Cyhoeddwyd 2011

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness gan Flora Cimmino, Johannes H. Schulte, Massimo Zollo, Jan Köster, Rogier Versteeg, Achille Iolascon, Angelika Eggert, Alexander Schramm

Cyhoeddwyd 2009

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis gan Kenneth Bryan, Marta Terrile, Isabella Bray, Raquel Domingo-Fernandéz, Karen M. Watters, Jan Köster, Rogier Versteeg, Raymond L. Stallings

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales gan Kathrin Teller, Doris Illner, Stefanie Thamm, Corella S. Casas-Delucchi, Rogier Versteeg, Mireille H. G. Indemans, Thomas Cremer, Marion Cremer

Cyhoeddwyd 2011

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma gan Janine Stutterheim, Lily Zappeij‐Kannegieter, Rogier Versteeg, H.N. Caron, C. Ellen van der Schoot, Godelieve A.M. Tytgat

Cyhoeddwyd 2011

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

Domain-wide regulation of gene expression in the human genome gan Hinco J. Gierman, Mireille H. G. Indemans, Jan Köster, Sandra Goetze, Jurgen Seppen, Dirk Geerts, Roel van Driel, Rogier Versteeg

Cyhoeddwyd 2007

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma gan Jan J. Molenaar, Marli E. Ebus, Jan Köster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron

Cyhoeddwyd 2008

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. gan Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Cyhoeddwyd 1989

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
16

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells gan Jan J. Molenaar, Marli E. Ebus, Dirk Geerts, Jan Köster, Fieke Lamers, Linda J. Valentijn, Ellen M. Westerhout, Rogier Versteeg, Huib N. Caron

Cyhoeddwyd 2009

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
17

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. gan Rogier Versteeg, K M Krüse-Wolters, Arianne C. Plomp, A. van Leeuwen, Nico J. Stam, Hidde L. Ploegh, D. J. Ruiter, Peter I. Schrier

Cyhoeddwyd 1989

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
18

The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification gan Dirk Geerts, Jan Köster, D.J. Albert, Dana‐Lynn T. Koomoa, David J. Feith, Anthony E. Pegg, Richard Volckmann, Huib N. Caron, Rogier Versteeg, André S. Bachmann

Cyhoeddwyd 2009

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
19

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification gan Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg

Cyhoeddwyd 2012

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
20

The Human Transcriptome Map Reveals Extremes in Gene Density, Intron Length, GC Content, and Repeat Pattern for Domains of Highly and Weakly Expressed Genes gan Rogier Versteeg, Barbera D. C. van Schaik, Marinus F. van Batenburg, Marco Roos, Ramin Monajemi, Huib N. Caron, Harmen J. Bussemaker, Antoine H. C. van Kampen

Cyhoeddwyd 2003

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Tumours outside the mutation box gan Rogier Versteeg

c-myc down-regulates class I HLA expression in human melanomas. gan Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters, D. J. Ruiter, Peter I. Schrier

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression gan Fieke Lamers, Linda Schild, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines gan Monique H. A. Kester, George G. J. M. Kuiper, Rogier Versteeg, Theo J. Visser

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene gan Gerben Schaaf, Mohamed Hamdi, Danny A. Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma gan Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma gan Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells gan Jens Bunt, Nancy E. Hasselt, Danny A. Zwijnenburg, Mohamed Hamdi, Jan Köster, Rogier Versteeg, Marcel Kool

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness gan Flora Cimmino, Johannes H. Schulte, Massimo Zollo, Jan Köster, Rogier Versteeg, Achille Iolascon, Angelika Eggert, Alexander Schramm

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis gan Kenneth Bryan, Marta Terrile, Isabella Bray, Raquel Domingo-Fernandéz, Karen M. Watters, Jan Köster, Rogier Versteeg, Raymond L. Stallings

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales gan Kathrin Teller, Doris Illner, Stefanie Thamm, Corella S. Casas-Delucchi, Rogier Versteeg, Mireille H. G. Indemans, Thomas Cremer, Marion Cremer

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma gan Janine Stutterheim, Lily Zappeij‐Kannegieter, Rogier Versteeg, H.N. Caron, C. Ellen van der Schoot, Godelieve A.M. Tytgat

Domain-wide regulation of gene expression in the human genome gan Hinco J. Gierman, Mireille H. G. Indemans, Jan Köster, Sandra Goetze, Jurgen Seppen, Dirk Geerts, Roel van Driel, Rogier Versteeg

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma gan Jan J. Molenaar, Marli E. Ebus, Jan Köster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. gan Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells gan Jan J. Molenaar, Marli E. Ebus, Dirk Geerts, Jan Köster, Fieke Lamers, Linda J. Valentijn, Ellen M. Westerhout, Rogier Versteeg, Huib N. Caron

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. gan Rogier Versteeg, K M Krüse-Wolters, Arianne C. Plomp, A. van Leeuwen, Nico J. Stam, Hidde L. Ploegh, D. J. Ruiter, Peter I. Schrier

Functional MYCN signature predicts outcome of neuroblastoma irrespective of <i>MYCN</i> amplification gan Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg

Canlyniadau Chwilio - Rogier Versteeg

Tumours outside the mutation box gan Rogier Versteeg

c-myc down-regulates class I HLA expression in human melanomas. gan Rogier Versteeg, IA Noordermeer, M. Krüse-Wolters, D. J. Ruiter, Peter I. Schrier

Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression gan Fieke Lamers, Linda Schild, Jan Köster, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines gan Monique H. A. Kester, George G. J. M. Kuiper, Rogier Versteeg, Theo J. Visser

Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated <i>RAS</i> Gene gan Gerben Schaaf, Mohamed Hamdi, Danny A. Zwijnenburg, Arjan Lakeman, Dirk Geerts, Rogier Versteeg, Marcel Kool

FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma gan Evan E. Santo, Peter Stroeken, Peter van Sluis, Jan Köster, Rogier Versteeg, Ellen M. Westerhout

A NOTCH3 Transcriptional Module Induces Cell Motility in Neuroblastoma gan Johan van Nes, Alvin Chan, Tim van Groningen, Peter van Sluis, Jan Köster, Rogier Versteeg

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells gan Jens Bunt, Nancy E. Hasselt, Danny A. Zwijnenburg, Mohamed Hamdi, Jan Köster, Rogier Versteeg, Marcel Kool

Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness gan Flora Cimmino, Johannes H. Schulte, Massimo Zollo, Jan Köster, Rogier Versteeg, Achille Iolascon, Angelika Eggert, Alexander Schramm

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis gan Kenneth Bryan, Marta Terrile, Isabella Bray, Raquel Domingo-Fernandéz, Karen M. Watters, Jan Köster, Rogier Versteeg, Raymond L. Stallings

A top-down analysis of Xa- and Xi-territories reveals differences of higher order structure at ≥ 20 Mb genomic length scales gan Kathrin Teller, Doris Illner, Stefanie Thamm, Corella S. Casas-Delucchi, Rogier Versteeg, Mireille H. G. Indemans, Thomas Cremer, Marion Cremer

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma gan Janine Stutterheim, Lily Zappeij‐Kannegieter, Rogier Versteeg, H.N. Caron, C. Ellen van der Schoot, Godelieve A.M. Tytgat

Domain-wide regulation of gene expression in the human genome gan Hinco J. Gierman, Mireille H. G. Indemans, Jan Köster, Sandra Goetze, Jurgen Seppen, Dirk Geerts, Roel van Driel, Rogier Versteeg

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma gan Jan J. Molenaar, Marli E. Ebus, Jan Köster, Peter van Sluis, Carel J.M. van Noesel, Rogier Versteeg, Huib N. Caron

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. gan Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells gan Jan J. Molenaar, Marli E. Ebus, Dirk Geerts, Jan Köster, Fieke Lamers, Linda J. Valentijn, Ellen M. Westerhout, Rogier Versteeg, Huib N. Caron

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. gan Rogier Versteeg, K M Krüse-Wolters, Arianne C. Plomp, A. van Leeuwen, Nico J. Stam, Hidde L. Ploegh, D. J. Ruiter, Peter I. Schrier

Functional MYCN signature predicts outcome of neuroblastoma irrespective of <i>MYCN</i> amplification gan Linda J. Valentijn, Jan Köster, Franciska Haneveld, Rachida Ait Aissa, Peter van Sluis, Marloes E.C. Broekmans, Jan J. Molenaar, Johan van Nes, Rogier Versteeg

Offerynnau Chwilio:

Pynciau Perthynol